How to Preserve Muscle Mass on Weight-Loss Drugs Like Wegovy

Health & Lifestyle
400

Listen to article (english)

Translate to Spanish or other 102 languages!

How can you preserve muscle mass if you are using GLP-1 drugs for weight loss? Top experts weigh in. Image for illustration purposes
How can you preserve muscle mass if you are using GLP-1 drugs for weight loss? Top experts weigh in. Image for illustration purposes

Mega Doctor News

- Advertisement -

The development of glucagon-like peptide-1 (GLP-1) drugs, such as Wegovy and Zepbound, has ushered in a new era in weight management. While these drugs can lead to significant weight loss, researchers and medical professionals have raised concerns about the accompanying loss of muscle tissue. This Special Feature discusses the challenges associated with assessing changes in muscle mass that accompany GLP-1 drug-induced weight loss, the potential impact of muscle mass loss, and how to preserve muscle mass.

Follow the link below to Medical News Today to read the full story:

https://www.medicalnewstoday.com/articles/how-to-preserve-muscle-mass-on-weight-loss-drugs-like-wegovy

- Advertisement -

Information: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
Texas A&M-McAllen Students Lead Two Health Fairs in RGV Colonias
Next article
No ‘One Size Fits All’ Treatment for Type 1 Diabetes, Study Finds

More Articles

STHS Behavioral’s Summer Mental Health Tips for Kids

STHS Behavioral urges families to prioritize emotional well-being by maintaining routines, encouraging social connections and fostering growth beyond the classroom.

New Insight Into the Iron-Retention Strategies of Colorectal Cancer Cells

Mega Doctor News by Michigan Medicine - University of Michigan Newswise — ANN ARBOR, Michigan...

Study: Weight Loss Drugs Cut Risk of Four Cancers by Half or More

Medical News Today The use of glucagon-like peptide-1 (GLP-1) receptor agonistTrusted Source medications continues...

FDA Approves Expanded Use of Kidney Cancer Treatment Rooted in UTSW Discovery

Belzutifan, a first-in-class drug that arose from scientific discoveries at UT Southwestern Medical Center, has been approved by the Food and Drug Administration to treat some patients with earlier stage kidney cancers in combination with an immunotherapy drug. This move marks the latest expansion of belzutifan’s indications after it was originally approved in 2021.
- Advertisement -